Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins

A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins

Thumbnail Image
Download
Name

nihms-1017984.pdf

Description
Accepted version
Size

1.57 MB

Format

Adobe PDF

Checksum (MD5)

387b77dc87bd5d411e2704b5482871f3

sword-2020-01-02T17:51:39.original.xml (130 B)
Original SWORD entry document
Author(s)
Cohen, Daniel Tzvi
•
Zhang, Chi
•
Fadzen, Colin M.
•
Mijalis, Alexander James
•
Hie, Liana
•
Johnson, Kenneth D.
•
Shriver, Zachary
•
Plante, Obadiah
•
Miller, Scott J.
•
Buchwald, Stephen Leffler
more
Date Issued
November 2018
Journal
Nature Chemistry
Publisher
Springer Science and Business Media LLC
Citation
Cohen, Daniel T. et al. "A chemoselective strategy for late-stage functionalization of complex small molecules with polypeptides and proteins." Nature Chemistry 11, 1 (November 2018): 78–85 © 2018, The Author(s), under exclusive licence to Springer Nature Limited
Version
Author's final manuscript
Abstract
Conjugates between proteins and small molecules enable access to a vast chemical space that is not achievable with either type of molecule alone; however, the paucity of specific reactions capable of functionalizing proteins and natural products presents a formidable challenge for preparing conjugates. Here we report a strategy for conjugating electron-rich (hetero)arenes to polypeptides and proteins. Our bioconjugation technique exploits the electrophilic reactivity of an oxidized selenocysteine residue in polypeptides and proteins, and the electron-rich character of certain small molecules to provide bioconjugates in excellent yields under mild conditions. This conjugation chemistry enabled the synthesis of peptide–vancomycin conjugates without the prefunctionalization of vancomycin. These conjugates have an enhanced in vitro potency for resistant Gram-positive and Gram-negative pathogens. Additionally, we show that a 6 kDa affibody protein and a 150 kDa immunoglobulin-G antibody could be modified without diminishing bioactivity. Keywords: biomaterials – protein; chemical modification; proteins
MIT Department
Massachusetts Institute of Technology. Department of Chemistry
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
https://hdl.handle.net/1721.1/123668
DOI of Published Version
https://doi.org/10.1038/s41557-018-0154-0
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.